NCT00396721
Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy treatment 2 completed NCT03719443
First in Human Study to Assess Safety of VIS649 in Healthy Subjects treatment 1 completed NCT05775042
Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy No drug interventions treatment 2 recruiting NCT05834738
Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy treatment 2 recruiting NCT04573920
Atrasentan in Patients With Proteinuric Glomerular Diseases treatment 2 active_not_recruiting NCT05942625
A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects No drug interventions treatment 1 recruiting NCT04578834
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients treatment 3 active_not_recruiting NCT04716231
Atacicept in Subjects with IgA Nephropathy treatment 3 recruiting NCT05687890
A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease No drug interventions treatment 2 active_not_recruiting NCT04438603
The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA Nephropathy No drug interventions Not Available Not Available unknown_status NCT05824390
A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy treatment 4 active_not_recruiting NCT03633864
Fecal Microbiota Transplantation for Refractory IgA Nephropathy treatment 2 unknown_status NCT02062684
BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration treatment 2 / 3 completed NCT01502579
An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data No drug interventions Not Available Not Available completed NCT06460987
Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy Not Available Not Available completed NCT03608033
Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy treatment 3 terminated NCT06209177
Study of ARO-CFB in Adult Healthy Volunteers and Patients With Complement-Mediated Kidney Disease No drug interventions treatment 1 recruiting NCT00885547
Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis treatment Not Available terminated NCT03001947
IgA Nephropathy Registration Initiative of High Quality (INSIGHT) No drug interventions Not Available Not Available recruiting NCT05383547
Bortezomib for Treating Glomerular Diseases treatment Not Available unknown_status NCT04805047
SodiUm Restriction by Behavioral Intervention No drug interventions supportive_care Not Available unknown_status NCT06419205
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G No drug interventions other 2 not_yet_recruiting NCT00319761
Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy treatment 4 completed NCT00870493
Aliskiren for Immunoglobulin A (IgA) Nephropathy treatment 3 completed NCT01103778
Pilot Study of Velcade® in IgA Nephropathy treatment 4 completed NCT04573478
Atrasentan in Patients With IgA Nephropathy treatment 3 active_not_recruiting NCT06580288
Effect of Finerenone in IgA Nephropathy treatment 3 not_yet_recruiting NCT01203007
Diet Intervention in Food Sensitive Patients With IgA Nephropathy No drug interventions treatment Not Available unknown_status NCT00793585
A Controlled Study of Uric Acid on the Progression of IgA Nephropathy treatment Not Available completed NCT00863252
Mycophenolate Mofetil for IgA Nephropathy treatment 4 completed NCT06065852
National Registry of Rare Kidney Diseases No drug interventions Not Available Not Available recruiting NCT02187900
Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f. treatment 3 unknown_status NCT00755859
"Steroids and Azathioprine Versus Steroids Alone in IgAN" treatment 4 completed NCT00657059
Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN) treatment 3 completed NCT03945318
Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN) treatment 1 / 2 active_not_recruiting NCT02954419
IgA Nephropathy Biomarkers Evaluation Study (INTEREST) No drug interventions Not Available Not Available recruiting NCT04858724
The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA) No drug interventions Not Available Not Available recruiting NCT00599963
Paricalcitol for the Treatment of Immunoglobulin A Nephropathy treatment 3 withdrawn NCT02231125
Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy treatment 4 unknown_status NCT05190848
Correlation of Microbiome and Metabonomics With IgA Nephropathy No drug interventions Not Available Not Available recruiting NCT00426348
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy treatment 4 completed NCT02526966
Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy No drug interventions diagnostic Not Available completed NCT04833374
Steroids Therapy in IgA Nephropathy With Crescents treatment 3 unknown_status NCT00856674
Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy No drug interventions treatment 1 terminated NCT03015974
Registry of IgA Nephropathy in Chinese Children Not Available Not Available recruiting NCT05528991
Oxford Classification and Clinical Remission After Initial Treatments in Patients With IgA Nephropathy No drug interventions Not Available Not Available recruiting NCT04525729
Rituximab and RASi in Patients With IgAN treatment 4 unknown_status NCT02808429
Efficacy and Safety of Atacicept in IgA Nephropathy treatment 2 terminated NCT00549692
Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy prevention 3 completed NCT02493101
The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients No drug interventions Not Available Not Available completed NCT05125068
Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN) treatment 2 terminated NCT00498368
Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy treatment 4 completed NCT01781312
Probiotics in IgA Nephropathy No drug interventions Not Available Not Available unknown_status NCT05398510
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject No drug interventions treatment 1 completed NCT04291781
A Study of RC18 Administered Subcutaneously to Subjects With IgA(Immunoglobulin A) Nephropathy No drug interventions treatment 2 completed NCT04042623
Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy treatment 2 terminated NCT05596708
Study of Telitacicept in Patients With Refractory IgA Nephropathy treatment 2 / 3 not_yet_recruiting NCT02112838
Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy treatment 2 completed NCT05083364
Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease No drug interventions treatment 1 recruiting NCT00767221
Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study treatment 2 completed NCT00554502
Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy No drug interventions treatment 3 completed NCT03188887
Treatment of IgA Nephropathy According to Renal Lesions treatment 3 completed NCT03929887
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis No drug interventions Not Available Not Available recruiting NCT01392833
Steroids and Azathioprine in Advanced IgAN treatment 3 completed NCT01538433
A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy No drug interventions Not Available Not Available completed NCT02662283
Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy treatment 2 / 3 unknown_status NCT03373461
Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation treatment 2 completed NCT01237028
Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers treatment Not Available completed NCT01224028
A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients treatment 2 completed NCT00922311
Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade treatment 4 completed NCT03366337
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX treatment 2 completed NCT03218852
Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy treatment 4 unknown_status NCT00301600
Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy treatment Not Available completed NCT05182775
A Clinical Research on the Use of Fecal Bacteria Transplantation for Treatment of IgA Nephropathy No drug interventions treatment Not Available recruiting NCT02471599
Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy No drug interventions treatment Not Available suspended NCT02433236
Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy treatment 2 withdrawn NCT06393036
The Effect of OSA on Severity and Prognosis of Patients With IgAN No drug interventions Not Available Not Available not_yet_recruiting NCT02052219
BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy treatment 3 withdrawn NCT03453619
Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies treatment 2 completed NCT02529722
Biomarkers for the Progression of IgA Nephropathy No drug interventions Not Available Not Available completed NCT05434325
TESTING -ON Post-Trial ObservatioNal Cohort Study No drug interventions Not Available Not Available recruiting NCT06350630
Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study treatment 2 not_yet_recruiting NCT01129557
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease treatment 4 terminated NCT00318474
Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy treatment 3 terminated NCT01758120
Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy treatment 4 unknown_status NCT01775527
IgA Nephropathy, Lymphocyte Homing and IgA Class Switch No drug interventions Not Available Not Available completed NCT00367562
Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy treatment 4 completed NCT03488368
Longterm Renal Oucomes of STOP-IgAN Trial Participants No drug interventions Not Available Not Available completed NCT04905212
A Study of Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy treatment 2 terminated NCT02981212
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy treatment 4 unknown_status NCT06454110
Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN) No drug interventions treatment 2 not_yet_recruiting NCT01451710
The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy treatment Not Available completed NCT01879514
Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath treatment Not Available unknown_status NCT01854814
The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients treatment Not Available completed NCT02382523
Acthar on Proteinuria in IgA Nephropathy Patients treatment 4 withdrawn NCT05016323
A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy. No drug interventions treatment 2 unknown_status NCT05852938
A Study of BION-1301 in Adults With IgA Nephropathy treatment 3 recruiting NCT04684745
Open-Label Extension Study of BION-1301 in IgA Nephropathy treatment 2 recruiting NCT01269021
An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN) treatment Not Available completed NCT03841448
A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN) treatment 2 terminated NCT04689074
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases No drug interventions Not Available Not Available completed NCT06291376
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN) treatment 3 recruiting NCT06564142
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) treatment 3 recruiting NCT06635772
A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy treatment 2 not_yet_recruiting NCT05097989
Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) treatment 2 active_not_recruiting NCT04564339
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) treatment 2 recruiting NCT05132621
The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy. No drug interventions Not Available Not Available unknown_status NCT04287985
Safety and Efficacy Study of VIS649 for IgA Nephropathy treatment 2 completed NCT05248659
Phase 2/3 Open-Label Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy treatment 2 / 3 enrolling_by_invitation NCT05162066
Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN) No drug interventions treatment 2 terminated NCT05856760
A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN treatment 2 active_not_recruiting NCT04663204
A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy treatment 2 active_not_recruiting NCT05248646
Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN) treatment 3 active_not_recruiting NCT05732402
An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases treatment 1 / 2 recruiting NCT05200871
Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy) No drug interventions Not Available Not Available completed NCT02384317
Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade treatment 2 completed NCT05003986
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases treatment 2 recruiting NCT01838239
Development of a Metabolic Assessment Tool for Chronic Kidney Disease No drug interventions basic_science Not Available completed NCT02605525
Efficacy and Safety of SM101 in the Treatment of IgA Nephropathy treatment 2 withdrawn NCT03762850
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy treatment 3 active_not_recruiting NCT04662723
Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy. treatment 4 recruiting